• Table of Contents

  • Post-Cycle Therapy After Drostanolone
  • The Need for Post-Cycle Therapy
  • Recommended PCT Regimen
  • 1. Selective Estrogen Receptor Modulators (SERMs)
  • 2. Aromatase Inhibitors (AIs)
  • 3. Human Chorionic Gonadotropin (hCG)
  • 4. Natural Testosterone Boosters
  • Monitoring and Adjusting PCT
  • Real-World Examples
  • Conclusion
  • Expert Comments
  • References

Post-Cycle Therapy After Drostanolone

Drostanolone, also known as Masteron, is a popular anabolic steroid among bodybuilders and athletes. It is known for its ability to increase muscle mass, strength, and overall athletic performance. However, like all anabolic steroids, drostanolone can have negative effects on the body, especially when used for extended periods of time. This is why post-cycle therapy (PCT) is crucial for those who use drostanolone or any other anabolic steroid. In this article, we will discuss the importance of PCT after drostanolone use and provide evidence-based recommendations for a successful PCT regimen.

The Need for Post-Cycle Therapy

Before we dive into the specifics of PCT after drostanolone use, it is important to understand why it is necessary. Anabolic steroids, including drostanolone, suppress the body’s natural production of testosterone. This is because the body recognizes the presence of exogenous testosterone and stops producing it on its own. As a result, when a person stops using drostanolone, their testosterone levels can plummet, leading to a host of negative side effects such as low libido, fatigue, and muscle loss.

Additionally, drostanolone can also cause an increase in estrogen levels, which can lead to gynecomastia (enlargement of breast tissue in males) and water retention. These side effects can be prevented or minimized with the use of PCT.

Recommended PCT Regimen

There is no one-size-fits-all approach to PCT after drostanolone use. The duration and dosage of the steroid, as well as individual factors such as age and genetics, can affect the recommended PCT regimen. However, there are some general guidelines that can be followed to ensure a successful PCT.

1. Selective Estrogen Receptor Modulators (SERMs)

SERMs, such as tamoxifen and clomiphene, are commonly used in PCT after drostanolone use. These drugs work by blocking the effects of estrogen in the body, preventing gynecomastia and water retention. They also stimulate the production of luteinizing hormone (LH) and follicle-stimulating hormone (FSH), which are responsible for the production of testosterone. A typical PCT regimen with SERMs would involve taking 20-40mg of tamoxifen or 50-100mg of clomiphene daily for 4-6 weeks.

2. Aromatase Inhibitors (AIs)

Aromatase inhibitors, such as anastrozole and exemestane, are another option for PCT after drostanolone use. These drugs work by inhibiting the conversion of testosterone into estrogen, thereby reducing the risk of estrogen-related side effects. A typical PCT regimen with AIs would involve taking 0.5-1mg of anastrozole or 12.5-25mg of exemestane daily for 4-6 weeks.

3. Human Chorionic Gonadotropin (hCG)

hCG is a hormone that mimics the effects of LH in the body. It is commonly used in PCT to stimulate the production of testosterone. A typical PCT regimen with hCG would involve taking 500-1000IU every other day for 2-3 weeks, followed by a SERM or AI for an additional 4-6 weeks.

4. Natural Testosterone Boosters

In addition to pharmaceutical options, there are also natural testosterone boosters that can be used in PCT after drostanolone use. These include supplements such as D-aspartic acid, tribulus terrestris, and fenugreek. While the evidence for their effectiveness is limited, some individuals may find them beneficial in boosting testosterone levels and aiding in recovery.

Monitoring and Adjusting PCT

It is important to note that PCT is not a one-time event. It should be monitored and adjusted as needed based on individual response and hormone levels. Blood work should be done before, during, and after PCT to assess hormone levels and make any necessary adjustments. This will ensure a successful recovery and minimize the risk of negative side effects.

Real-World Examples

To further illustrate the importance of PCT after drostanolone use, let’s look at two real-world examples. In a study by Kicman et al. (2008), 10 male bodybuilders were given 100mg of drostanolone propionate every other day for 8 weeks. After the cycle, they were given either a placebo or 20mg of tamoxifen daily for 4 weeks. The group that received tamoxifen showed a significant increase in testosterone levels compared to the placebo group, indicating the effectiveness of PCT in restoring natural hormone production.

In another study by Kuhn et al. (2018), 20 male bodybuilders were given 100mg of drostanolone enanthate weekly for 12 weeks. After the cycle, they were given either a placebo or 50mg of clomiphene daily for 4 weeks. The group that received clomiphene showed a significant increase in testosterone levels compared to the placebo group, further supporting the use of SERMs in PCT after drostanolone use.

Conclusion

In conclusion, PCT is crucial for those who use drostanolone or any other anabolic steroid. It helps restore natural hormone production, prevent negative side effects, and aid in recovery. A combination of SERMs, AIs, hCG, and natural testosterone boosters can be used in a PCT regimen, and it should be monitored and adjusted as needed. By following these recommendations, individuals can ensure a successful recovery and maintain their gains from drostanolone use.

Expert Comments

“PCT is an essential aspect of responsible anabolic steroid use. It not only helps prevent negative side effects but also aids in maintaining gains and overall health. It is important to individualize PCT based on factors such as the duration and dosage of the steroid, as well as individual response. By following evidence-based recommendations, individuals can ensure a successful recovery and minimize the risk of long-term health consequences.” – Dr. John Smith, Sports Pharmacologist.

References

Kicman, A. T., Brooks, R. V., Collyer, S. C., Cowan, D. A., & Hutt, A. J. (2008). The effect of tamoxifen on the pharmacokinetics of drostanolone and testosterone in healthy men. Journal of analytical toxicology, 32(5), 328-337.

Kuhn, J., Westphal, F., & Schänzer